Yesterday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on the Pfizer booster was so problematic as to make a reasonable person wonder whether our vaccine strategy was ever about science.
Yesterday’s FDA Vaccines and Related Biological Products (VRBPAC) meeting on the Pfizer booster was so problematic as to make a reasonable person wonder whether our vaccine strategy was ever about science.